← SynDRA
EFATUTAZONE
SynDRA canonical compound SYN0038261 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PPARG |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- PPAR receptor agonist
- PPARG AGONIST
- Peroxisome proliferator-activated receptor gamma agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Efatutazona
- Inolitazone
- CS-7017 ANHYDROUS
- 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-Thiazolidinedione
- Efatutazone [INN]
- RS5444
- CS-7017
- SCHEMBL3246054
- CHEMBL3545280
- JCYNMRJCUYVDBC-UHFFFAOYSA-N
- Efatutazone;CS-7017;RS5444
- BCP07478
- AKOS030526729
- DB11894
- CS-0778
- KB-77905
- DA-07988
- HY-14792
- QC-10456
- 4CA-1384
- FT-0737589
- 5-[4-[6-(4-amino-3 ,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione
- M17ILL71MC
- efatutazonum
- RefChem:590604
- UNII-M17ILL71MC
- MFCD13194772
- EFATUTAZONE [WHO-DD]
- orb1308191
- SCHEMBL29379011
- C27H26N4O4S
- GLXC-15908
- YIA13237
- BDBM50450236
- EX-A12328
- NSC764579
- NSC-764579
- NCGC00378991-01
Look up EFATUTAZONE in the interactive SynDRA portal →